LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 HG-6-64-01
3.33
uM
LJP6
 2
M02
 72
hr
 1097 1484 3769 0.3937 0.1447
BT-20 HG-6-64-01
3.33
uM
LJP6
 3
M02
 72
hr
 1097 1527 3769 0.4051 0.1608
BT-20 WH-4-025
3.33
uM
LJP5
 1
O08
 72
hr
 1097 1878 3769 0.4982 0.2922
BT-20 WH-4-025
3.33
uM
LJP5
 2
O08
 72
hr
 1097 1711 3769 0.4539 0.2297
BT-20 WH-4-025
3.33
uM
LJP5
 3
O08
 72
hr
 1097 1477 3769 0.3918 0.1421
BT-20 WZ-4-145
3.33
uM
LJP6
 1
J20
 72
hr
 1097 2005 3769 0.5319 0.3397
BT-20 WZ-4-145
3.33
uM
LJP6
 2
J20
 72
hr
 1097 1954 3769 0.5184 0.3206
BT-20 WZ-4-145
3.33
uM
LJP6
 3
J20
 72
hr
 1097 2179 3769 0.5781 0.4048
BT-20 XMD16-144
3.33
uM
LJP5
 1
M08
 72
hr
 1097 1344 3769 0.3565 0.0923
BT-20 XMD16-144
3.33
uM
LJP5
 2
M08
 72
hr
 1097 1315 3769 0.3489 0.0815
BT-20 XMD16-144
3.33
uM
LJP5
 3
M08
 72
hr
 1097 1277 3769 0.3388 0.0673
BT-20 Brivanib
3.33
uM
LJP5
 1
P14
 72
hr
 1097 3736 3769 0.9911 0.9875
BT-20 Brivanib
3.33
uM
LJP5
 2
P14
 72
hr
 1097 3866 3769 1.0256 1.0361
BT-20 Brivanib
3.33
uM
LJP5
 3
P14
 72
hr
 1097 3396 3769 0.9009 0.8602
BT-20 Buparlisib
3.33
uM
LJP5
 1
H02
 72
hr
 1097 761 3769 0.2019 -0.1258
BT-20 Buparlisib
3.33
uM
LJP5
 2
H02
 72
hr
 1097 717 3769 0.1902 -0.1423
BT-20 Buparlisib
3.33
uM
LJP5
 3
H02
 72
hr
 1097 718 3769 0.1905 -0.1419
BT-20 BX-912
3.33
uM
LJP5
 1
L20
 72
hr
 1097 3685 3769 0.9776 0.9684
BT-20 BX-912
3.33
uM
LJP5
 2
L20
 72
hr
 1097 3635 3769 0.9643 0.9497
BT-20 BX-912
3.33
uM
LJP5
 3
L20
 72
hr
 1097 3731 3769 0.9898 0.9856
BT-20 Canertinib
3.33
uM
LJP6
 1
H08
 72
hr
 1097 2677 3769 0.7102 0.5912
BT-20 Canertinib
3.33
uM
LJP6
 2
H08
 72
hr
 1097 2772 3769 0.7354 0.6267
BT-20 Canertinib
3.33
uM
LJP6
 3
H08
 72
hr
 1097 2566 3769 0.6807 0.5496
BT-20 Celastrol
3.33
uM
LJP6
 1
G08
 72
hr
 1097 514 3769 0.1364 -0.2183
BT-20 Celastrol
3.33
uM
LJP6
 2
G08
 72
hr
 1097 498 3769 0.1321 -0.2243